Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoon-Jae Cho

Showing results (91-100 of 127) with videos related to

Pageof 13
Sort By:
Cell Reports|December 2, 2014
Expression quantitative trait loci and receptor pharmacology implicate Arg1 and the GABA-A receptor as therapeutic targets in neuroblastomaChristopher S Hackett, David A Quigley, Robyn A Wong, et al.
Nature Medicine|November 16, 2010
Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathwayZainab Jagani, E Lorena Mora-Blanco, Courtney G Sansam, et al.
Science Signaling|September 13, 2018
Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastomaTeresa Purzner, James Purzner, Taylor Buckstaff, et al.
Scientific Reports|June 4, 2016
IGF1R as a Key Target in High Risk, Metastatic MedulloblastomaMatthew N Svalina, Ken Kikuchi, Jinu Abraham, et al.
Neuro-Oncology|June 11, 2016
Pediatric high-grade glioma: biologically and clinically in need of new thinkingChris Jones, Matthias A Karajannis, David T W Jones, et al.
Acta Neuropathologica|February 19, 2015
Medulloblastoma subgroups remain stable across primary and metastatic compartmentsXin Wang, Adrian M Dubuc, Vijay Ramaswamy, et al.
Nature Medicine|June 30, 2014
Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibitionYujie Tang, Sharareh Gholamin, Simone Schubert, et al.
Acta Neuropathologica|February 24, 2012
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomasMarcel Kool, Andrey Korshunov, Marc Remke, et al.
Oncotarget|April 9, 2016
Medulloblastoma-associated DDX3 variant selectively alters the translational response to stressSekyung Oh, Ryan A Flynn, Stephen N Floor, et al.
Science Translational Medicine|March 17, 2017
Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumorsSharareh Gholamin, Siddhartha S Mitra, Abdullah H Feroze, et al.
Pageof 13

Showing results (91-100 of 127) with videos related to

Sort By:
Pageof 13
Cell Reports|December 2, 2014
Expression quantitative trait loci and receptor pharmacology implicate Arg1 and the GABA-A receptor as therapeutic targets in neuroblastomaChristopher S Hackett, David A Quigley, Robyn A Wong, et al.
Nature Medicine|November 16, 2010
Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathwayZainab Jagani, E Lorena Mora-Blanco, Courtney G Sansam, et al.
Science Signaling|September 13, 2018
Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastomaTeresa Purzner, James Purzner, Taylor Buckstaff, et al.
Scientific Reports|June 4, 2016
IGF1R as a Key Target in High Risk, Metastatic MedulloblastomaMatthew N Svalina, Ken Kikuchi, Jinu Abraham, et al.
Neuro-Oncology|June 11, 2016
Pediatric high-grade glioma: biologically and clinically in need of new thinkingChris Jones, Matthias A Karajannis, David T W Jones, et al.
Acta Neuropathologica|February 19, 2015
Medulloblastoma subgroups remain stable across primary and metastatic compartmentsXin Wang, Adrian M Dubuc, Vijay Ramaswamy, et al.
Nature Medicine|June 30, 2014
Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibitionYujie Tang, Sharareh Gholamin, Simone Schubert, et al.
Acta Neuropathologica|February 24, 2012
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomasMarcel Kool, Andrey Korshunov, Marc Remke, et al.
Oncotarget|April 9, 2016
Medulloblastoma-associated DDX3 variant selectively alters the translational response to stressSekyung Oh, Ryan A Flynn, Stephen N Floor, et al.
Science Translational Medicine|March 17, 2017
Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumorsSharareh Gholamin, Siddhartha S Mitra, Abdullah H Feroze, et al.
Pageof 13